1. EMBR-03. PINEOBLASTOMA: A POOLED OUTCOME STUDY OF NORTH AMERICAN AND AUSTRALIAN THERAPEUTIC DATA. (1st June 2021) Authors: Hansford, Jordan; Huang, Jie; Dodgshun, Andrew; Li, Bryan; Hwang, Eugene; Leary, Sarah; Gajjar, Amar; Von Hoff, Katja; Endersby, Raelene; Wells, Olivia; Wray, Alison; Kotecha, Rishi; Raleigh, David; Stoller, Schuyler; Mueller, Sabine; Schild, Steven; Bandopadhayay, Pratiti; Fouladi, Maryam; Bouff... Journal: Neuro-oncology Issue: Volume 23(2021)Supplement 1 Page Start: i6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. GCT-33. A PHASE 2 TRIAL OF RESPONSE-BASED RADIATION THERAPY FOR PATIENTS WITH LOCALIZED CENTRAL NERVOUS SYSTEM GERM CELL TUMORS: A CHILDREN'S ONCOLOGY GROUP (COG) STUDY. IMPACT OF RAPID CENTRAL RADIOTHERAPY REVIEW ON RADIOTHERAPY QUALITY AND PATTERN OF FAILURE FOR NON-GERMINOMATOUS GERM CELL TUMORS. (4th December 2020) Authors: Murphy, Erin S; Dhall, Girish; Fangusaro, Jason; Bartels, Ute; Fouladi, Maryam; Shaw, Dennis; Khatua, Soumen; Panigraphy, Ashok; Souweidane, Mark; Gajjar, Amar; Williams-Hughes, Chris; Onar, Arzu; Wu, Shengjie; Haas-Kogan, Daphne; MacDonald, Shannon Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 3 Page Start: iii334 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. IMMU-09. OUTCOME OF PATIENTS WITH RECURRENT DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) TREATED WITH PEMBROLIZUMAB (ANTI-PD-1): A PEDIATRIC BRAIN TUMOR CONSORTIUM STUDY (PBTC045). Issue 2 (22nd June 2018) Authors: Hwang, Eugene; Onar, Arzu; Young-Poussaint, Tina; Mitchell, Duane; Kilburn, Lindsay; Margol, Ashley; Gilheeny, Stephen; Lin, Tong; Dunkel, Ira; Fouladi, Maryam Journal: Neuro-oncology Issue: Volume 20:Issue 2(2018)supplement 2 Page Start: i100 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. IMMU-09. OUTCOME OF PATIENTS WITH RECURRENT DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) TREATED WITH PEMBROLIZUMAB (ANTI-PD-1): A PEDIATRIC BRAIN TUMOR CONSORTIUM STUDY (PBTC045). Issue 2 (22nd June 2018) Authors: Hwang, Eugene; Onar, Arzu; Young-Poussaint, Tina; Mitchell, Duane; Kilburn, Lindsay; Margol, Ashley; Gilheeny, Stephen; Lin, Tong; Dunkel, Ira; Fouladi, Maryam Journal: Neuro-oncology Issue: Volume 20:Issue 2(2018)supplement 2 Page Start: i100 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. MEDB-69. Clinical and molecular meta-analysis of three major medulloblastoma clinical trials (ACNS0331, SJMB03, ACNS0332) uncovers novel strategies to improve risk-stratified therapy. (3rd June 2022) Authors: Smith, Kyle S; Billups, Catherine A; Dhanda, Sandeep K; Bihannic, Laure; Vasilyeva, Aksana; Li, Yimei; Michalski, Jeff M; Olsen, James M; Leary, Sarah; Fouladi, Maryam; Gajjar, Amar; Onar, Arzu; Northcott, Paul A; Robinson, Giles W Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 1 Page Start: i122 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Phase I trial of p28 (NSC745104), a non-HDM2-mediated peptide inhibitor of p53 ubiquitination in pediatric patients with recurrent or progressive central nervous system tumors: A Pediatric Brain Tumor Consortium Study. Issue 9 (1st September 2016) Authors: Lulla, Rishi R.; Goldman, Stewart; Yamada, Tohru; Beattie, Craig W.; Bressler, Linda; Pacini, Michael; Pollack, Ian F.; Fisher, Paul Graham; Packer, Roger J.; Dunkel, Ira J.; Dhall, Girish; Wu, Shengjie; Onar, Arzu; Boyett, James M.; Fouladi, Maryam Journal: Neuro-oncology Issue: Volume 18:Issue 9(2016:Sep.) Page Start: 1319 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗